A phase 1/2 study of Serum Institute of India adjuvanted coronavirus vaccine
Latest Information Update: 31 Dec 2020
At a glance
- Drugs Adjuvanted coronavirus vaccine-Serum Institute of India (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- 31 Dec 2020 New trial record
- 23 Dec 2020 According to a Serum Institute of India and Dynavax Technologies media release, the first participant have been dosed in the Phase 1 part of this study.